On July 4th, Medace was honoured by a visit of Dr. Leonard Pinchuk who provided a unique lecture to the Medace community at the Medace facilities. Dr. Pinchuk is a very successful serial inventor and entrepreneur in biomedical engineering, with more than 128 US patents and 90 publications.
Hosted at the Medace facility this enlightening event appealed to many of our clients and partners. Dr. Pinchuk’s lecture was nothing short of remarkable, as he effortlessly shared his vast knowledge and experience with a profound passion that resonated with everyone present.
During the lecture, Dr. Pinchuk delved into the fascinating world of biomedical innovation, captivating the audience with his incredible journey as an inventor and entrepreneur. His ability to seamlessly bridge the gap between theory and (clinical) practice inspired many of the audience members to reach for new heights in their own emerging companies.
The lecture was an invaluable opportunity for all attendees, offering a rare chance to learn from one of the industry’s most accomplished minds. Dr. Pinchuk’s ability to distil complex concepts into understandable and relatable narratives was truly remarkable, making the content accessible to both experts and upcoming researchers alike.
Dr. Pinchuk who has been working with glaucoma surgeon Prof Dr. Henny Beckers and Dr. Christian Bertens on the next generation glaucoma devices, visited the Medace development and manufacturing facility. The newly established company PEYEONEER Medtech BV will be working with the Medace team to get this new device ready for clinical production and testing.
PEYEONEER MedTech BV is dedicated to revolutionizing the field of ophthalmology and addressing the critical challenge of preventing blindness caused by glaucoma. As the leading cause of irreversible blindness worldwide, glaucoma affects millions of lives. Our mission is to develop a novel glaucoma implant that will significantly enhance patient outcomes and quality of life.
About Dr. Leonard Pinchuk
He has cofounded 10 companies where his major accomplishments include invention of the Nylon 12 angioplasty balloon, helical wire stent, modular stent-graft, a drug-eluting stent (TAXUS®), several biomaterials (SIBS), a novel glaucoma tube (the InnFocus MicroShunt®), and the next generation intraocular lens. He is also Distinguished Research Professor of Biomedical Engineering at the University of Miami.
Dr. Pinchuk started his career at Cordis Corporation and left in 1987 to cofound Corvita Corporation (angioplasty catheters, stents, stent-grafts). Corvita was taken public (1994), acquired by Pfizer, Inc. (1996), and then sold to Boston Scientific Corporation (1998). Desiring to return to the startup setting, Dr. Pinchuk founded Innovia LLC (2002), incubating many companies in the fields of intraocular lenses, glaucoma shunts, radiation oncology, urology, gene therapy, and others. In 2016 Santen Pharmaceutical Co., Ltd. acquired his current company, InnFocus, Inc., where he is now chief scientific officer.
